FMP
Forward Pharma A/S
FWP
NASDAQ
Inactive Equity
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.
1.95 USD
0 (0%)
We are unable to load the chart at this time.